Drug Shortage Report for M-ESCITALOPRAM
| Report ID | 225515 |
| Drug Identification Number | 02471418 |
| Brand name | M-ESCITALOPRAM |
| Common or Proper name | M-ESCITALOPRAM |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESCITALOPRAM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-11 |
| Estimated end date | 2024-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-04-18 | French | Compare |
| v1 | 2024-04-18 | English | Compare |
Showing 1 to 2 of 2